Clinical investigations of the regulation of cellular metabolism are needed to assess this possibility, as we found that genes such as GSTM1, MYO3B, GSTM5, and ATP6V0E2 showed significant epigenetic modifications in ME/CFS. Here, GSTM1 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.